SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-22-007879
Filing Date
2022-10-24
Accepted
2022-10-24 16:16:10
Documents
14
Period of Report
2022-10-19
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 FORM 8-K upxi_8k.htm   iXBRL 8-K 21972
  Complete submission text file 0001477932-22-007879.txt   144208

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA upxi-20221019.xsd EX-101.SCH 5720
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE upxi-20221019_lab.xml EX-101.LAB 14660
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE upxi-20221019_cal.xml EX-101.CAL 898
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE upxi-20221019_pre.xml EX-101.PRE 9272
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE upxi-20221019_def.xml EX-101.DEF 2099
8 EXTRACTED XBRL INSTANCE DOCUMENT upxi_8k_htm.xml XML 3575
Mailing Address 17129 US HWY 19 N. CLEARWATER FL 33760
Business Address 17129 US HWY 19 N. CLEARWATER FL 33760 701-353-5425
UPEXI, INC. (Filer) CIK: 0001775194 (see all company filings)

IRS No.: 833378978 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-40535 | Film No.: 221326215
SIC: 2833 Medicinal Chemicals & Botanical Products